When should clopidogrel be stopped prior to cataract surgery?

Clopidogrel Does NOT Need to Be Stopped Before Cataract Surgery

For routine phacoemulsification cataract surgery with topical anesthesia and clear corneal incision, continue clopidogrel without interruption. The evidence consistently demonstrates that cataract surgery can be safely performed in patients on clopidogrel therapy, including dual antiplatelet therapy with aspirin, without increased risk of sight-threatening hemorrhagic complications 1, 2.

Evidence-Based Rationale

Cataract Surgery is Low-Risk for Bleeding

The research specifically examining cataract surgery shows:

• No sight-threatening hemorrhages occurred in patients continuing dual antiplatelet therapy (aspirin + clopidogrel) during phacoemulsification with topical anesthesia 1
• Minor complications only: While subconjunctival hemorrhage rates increased (4.4% vs 1.7% in non-users), there were no cases of anterior chamber hemorrhage, vitreous hemorrhage, or suprachoroidal hemorrhage in the clopidogrel group 2
• The large Cataract National Dataset audit of 48,862 operations found no significant increase in potentially sight-threatening complications despite increased minor bleeding 2

Risk of Stopping Clopidogrel

The FDA label explicitly warns that discontinuing clopidogrel increases cardiovascular event risk 3. This is particularly critical because:

• Premature withdrawal carries a 10% risk of all vascular events 4
• In patients with drug-eluting stents, stopping clopidogrel can cause stent thrombosis with potentially fatal consequences 4
• The cardiovascular risks of stopping antiplatelet therapy far outweigh the minimal bleeding risks in routine cataract surgery

When Clopidogrel SHOULD Be Stopped (5 Days Minimum)

Only stop clopidogrel if using regional anesthesia (peribulbar or retrobulbar blocks):

• The FDA label states: "When possible, interrupt therapy with clopidogrel for five days prior to surgery with a major risk of bleeding" 3
• The ACCP guideline recommends stopping P2Y12 inhibitors (including clopidogrel) at least 5 days before procedures with major bleeding risk 5
• One study showed increased minor complications (8.0% vs 4.3%) with sharp needle blocks in clopidogrel users, though no sight-threatening events occurred 2

Resume clopidogrel as soon as hemostasis is achieved post-operatively 3.

Clinical Algorithm

Step 1: Determine anesthesia type

• Topical anesthesia with clear corneal incision → Continue clopidogrel
• Regional block (peribulbar/retrobulbar) → Proceed to Step 2

Step 2: Assess cardiovascular risk

• Recent drug-eluting stent (<12 months) or acute coronary syndrome → Continue clopidogrel (cardiovascular risk too high)
• Stable cardiovascular disease → Stop clopidogrel 5 days before surgery, resume immediately post-op

Step 3: Coordinate with cardiology

• For high-risk cardiac patients requiring regional anesthesia, consider switching to topical anesthesia rather than stopping clopidogrel

Common Pitfalls to Avoid

• Don't reflexively stop clopidogrel for routine cataract surgery—this outdated practice increases cardiovascular risk unnecessarily
• Don't confuse cataract surgery with other ophthalmic procedures—vitreoretinal and glaucoma surgeries may have different bleeding risk profiles 6
• Don't stop clopidogrel without cardiology consultation in patients with recent stents or acute coronary syndromes
• Don't use the 5-day rule from CABG surgery (which has massive bleeding risks) and apply it to low-risk cataract surgery 5

The evidence firmly supports continuing clopidogrel for modern phacoemulsification cataract surgery with topical anesthesia, as the cardiovascular risks of stopping far exceed the minimal risk of non-sight-threatening bleeding complications.